Page last updated: 2024-10-18

dalteparin and Bacteremia

dalteparin has been researched along with Bacteremia in 9 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Bacteremia: The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.

Research Excerpts

ExcerptRelevanceReference
"Lemierre's syndrome is a potentially fatal disease that usually presents with oropharyngeal infection, followed by sepsis, thrombosis of the internal jugular vein and septic emboli."2.45Unusual presentation of Lemierre's syndrome: two cases and a review. ( Brandjes, DP; Gerdes, VE; Soesan, M; van Gorp, EC; van Wissen, M, 2009)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's5 (55.56)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Wissen, M1
Gerdes, VE1
van Gorp, EC1
Brandjes, DP1
Soesan, M1
Ruiz-Valverde, MP1
Barberà, JR1
Segarra, A1
Capdevila, JA1
Evangelista, A1
Piera, L1
Peetermans, M1
Liesenborghs, L1
Peerlinck, K1
Wijngaerden, EV1
Gheysens, O1
Goffin, KE1
Hoylaerts, MF1
Jacquemin, M1
Verhaegen, J1
Peetermans, WE1
Verhamme, P1
Vanassche, T1
Pruitt, LG1
Mosley, JC1
Lasseigne, RF1
Amezyane, T1
Abouzahir, A1
El Kharrass, A1
Bassou, D1
Fatihi, J1
Hammi, S1
Mahassin, F1
Ghafir, D1
Ohayon, V1
Lai, TF1
Wu, J1
Henderson, T1
Winlaw, W1
Malcolm, SJ1
Fasano, R1
Kent, P1
Valentino, L1
Keller, JE1
Hindman, JW1
Mehall, JR1
Smith, SD1

Reviews

2 reviews available for dalteparin and Bacteremia

ArticleYear
Unusual presentation of Lemierre's syndrome: two cases and a review.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2009, Volume: 20, Issue:6

    Topics: Acenocoumarol; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Deglutition Disorders; Diarrhea; F

2009
Superior vena cava thrombus treated with low-dose, peripherally administered recombinant tissue plasminogen activator in a child: case report and review of the literature.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:12

    Topics: Anti-Bacterial Agents; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; C

2005

Trials

1 trial available for dalteparin and Bacteremia

ArticleYear
Targeting Coagulase Activity in Staphylococcus aureus Bacteraemia: A Randomized Controlled Single-Centre Trial of Staphylothrombin Inhibition.
    Thrombosis and haemostasis, 2018, Volume: 118, Issue:5

    Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithro

2018

Other Studies

6 other studies available for dalteparin and Bacteremia

ArticleYear
Successful treatment of catheter-related sepsis and extraluminal catheter thrombosis with vancomycin and fraxiparin without catheter removal.
    Nephron, 1997, Volume: 75, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Catheterization, Central Venous; Catheters

1997
Bacteremia and Deep Vein Thrombosis in an Infant.
    The Journal of emergency medicine, 2016, Volume: 50, Issue:5

    Topics: Anti-Bacterial Agents; Anticoagulants; Bacteremia; Ceftriaxone; Clindamycin; Edema; Emergency Servic

2016
[Septic pylephlebitis associated with Enterobacter cloacae septicemia].
    Journal des maladies vasculaires, 2010, Volume: 35, Issue:1

    Topics: Abdominal Pain; Adult; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Ceftriaxone; Community-Acq

2010
Septic superior ophthalmic vein thrombosis: to coagulate or not to coagulate?
    Clinical & experimental ophthalmology, 2002, Volume: 30, Issue:6

    Topics: Anticoagulants; Bacteremia; Enoxaparin; Humans; Orbit; Orbital Diseases; Staphylococcal Infections;

2002
Septic superior ophthalmic vein thrombosis: enoxaparin needs to be monitored.
    Clinical & experimental ophthalmology, 2002, Volume: 30, Issue:6

    Topics: Anticoagulants; Bacteremia; Drug Monitoring; Enoxaparin; Humans; Orbit; Orbital Diseases; Staphyloco

2002
Enoxaparin inhibits fibrin sheath formation and decreases central venous catheter colonization following bacteremic challenge.
    Critical care medicine, 2006, Volume: 34, Issue:5

    Topics: Animals; Anticoagulants; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Enoxapa

2006